Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand NM Ferguson, D Laydon, G Nedjati-Gilani, N Imai, K Ainslie, M Baguelin, ... Imperial College London, 2020 | 4956 | 2020 |
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe S Flaxman, S Mishra, A Gandy, HJT Unwin, TA Mellan, H Coupland, ... Nature 584 (7820), 257-261, 2020 | 4046* | 2020 |
The impact of COVID-19 and strategies for mitigation and suppression in low-and middle-income countries PGT Walker, C Whittaker, OJ Watson, M Baguelin, P Winskill, A Hamlet, ... Science 369 (6502), 413-422, 2020 | 940 | 2020 |
Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study AB Hogan, BL Jewell, E Sherrard-Smith, JF Vesga, OJ Watson, ... The Lancet global health 8 (9), e1132-e1141, 2020 | 832 | 2020 |
The global impact of COVID-19 and strategies for mitigation and suppression PGT Walker, C Whittaker, O Watson, M Baguelin, KEC Ainslie, S Bhatia, ... Imperial College London 26, 1-19, 2020 | 694 | 2020 |
Reduction in mobility and COVID-19 transmission P Nouvellet, S Bhatia, A Cori, KEC Ainslie, M Baguelin, S Bhatt, ... Nature communications 12 (1), 1-9, 2021 | 571 | 2021 |
Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Imperial College COVID-19 Response Team NM Ferguson, D Laydon, G Nedjati-Gilani, N Imai, K Ainslie, M Baguelin, ... Imperial College COVID-19 Response Team 20 (10.25561), 77482, 2020 | 381 | 2020 |
Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study NC Grassly, M Pons-Salort, EPK Parker, PJ White, NM Ferguson, ... The Lancet Infectious Diseases 20 (12), 1381-1389, 2020 | 210 | 2020 |
Response to COVID-19 in South Korea and implications for lifting stringent interventions A Dighe, L Cattarino, G Cuomo-Dannenburg, J Skarp, N Imai, S Bhatia, ... BMC medicine 18, 1-12, 2020 | 198 | 2020 |
SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic H Ward, C Atchison, M Whitaker, KEC Ainslie, J Elliott, L Okell, R Redd, ... Nature communications 12 (1), 905, 2021 | 188 | 2021 |
State-level tracking of COVID-19 in the United States HJT Unwin, S Mishra, VC Bradley, A Gandy, TA Mellan, H Coupland, ... Nature communications 11 (1), 6189, 2020 | 177 | 2020 |
Evidence of initial success for China exiting COVID-19 social distancing policy after achieving containment KEC Ainslie, CE Walters, H Fu, S Bhatia, H Wang, X Xi, M Baguelin, ... Wellcome Open Research 5, 2020 | 147 | 2020 |
Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults H Ward, G Cooke, C Atchison, M Whitaker, J Elliott, M Moshe, JC Brown, ... MedRxiv, 2020.10. 26.20219725, 2020 | 141 | 2020 |
Report 21: Estimating COVID-19 cases and reproduction number in Brazil TA Mellan, HH Hoeltgebaum, S Mishra, C Whittaker, RP Schnekenberg, ... | 141 | 2020 |
Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults H Ward, CJ Atchison, M Whitaker, KEC Ainslie, J Elliott, LC Okell, R Redd, ... | 134 | 2020 |
Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant P Elliott, D Haw, H Wang, O Eales, CE Walters, KEC Ainslie, C Atchison, ... Science 374 (6574), eabl9551, 2021 | 120 | 2021 |
Resurgence of SARS-CoV-2: detection by community viral surveillance S Riley, KEC Ainslie, O Eales, CE Walters, H Wang, C Atchison, ... Science 372 (6545), 990-995, 2021 | 110 | 2021 |
Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Imperial College London, 2020 NM Ferguson, D Laydon, G Nedjati-Gilani, N Imai, K Ainslie, M Baguelin, ... Publish in The International Arabic Journal of Antimicrobial Agents, 2020 | 96 | 2020 |
Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults H Ward, GS Cooke, C Atchison, M Whitaker, J Elliott, M Moshe, JC Brown, ... The Lancet Regional Health–Europe 4, 2021 | 82 | 2021 |
Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B. 1.617. 2), the Netherlands, August to September 2021 B de Gier, S Andeweg, JA Backer, SJM Hahné, S van den Hof, ... Eurosurveillance 26 (44), 2100977, 2021 | 80 | 2021 |